Atria Investments Inc Sells 2,735 Shares of Avantor, Inc. (NYSE:AVTR)

Atria Investments Inc lessened its position in Avantor, Inc. (NYSE:AVTR) by 17.2% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 13,190 shares of the company’s stock after selling 2,735 shares during the quarter. Atria Investments Inc’s holdings in Avantor were worth $278,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other large investors have also added to or reduced their stakes in the company. MassMutual Private Wealth & Trust FSB raised its stake in shares of Avantor by 99.5% during the fourth quarter. MassMutual Private Wealth & Trust FSB now owns 1,253 shares of the company’s stock worth $26,000 after acquiring an additional 625 shares in the last quarter. Smartleaf Asset Management LLC raised its position in Avantor by 106.3% in the 4th quarter. Smartleaf Asset Management LLC now owns 1,611 shares of the company’s stock worth $34,000 after purchasing an additional 830 shares during the period. Global Retirement Partners LLC lifted its stake in Avantor by 76.7% in the fourth quarter. Global Retirement Partners LLC now owns 2,459 shares of the company’s stock worth $52,000 after purchasing an additional 1,067 shares during the last quarter. UMB Bank n.a. boosted its position in Avantor by 56.3% during the fourth quarter. UMB Bank n.a. now owns 2,981 shares of the company’s stock valued at $63,000 after buying an additional 1,074 shares during the period. Finally, CKW Financial Group grew its stake in shares of Avantor by 116.7% during the fourth quarter. CKW Financial Group now owns 5,200 shares of the company’s stock valued at $110,000 after buying an additional 2,800 shares during the last quarter. Hedge funds and other institutional investors own 95.08% of the company’s stock.

Wall Street Analyst Weigh In

AVTR has been the subject of a number of recent research reports. Wells Fargo & Company lowered their target price on Avantor from $28.00 to $25.00 and set an “overweight” rating for the company in a research note on Monday, February 10th. Royal Bank of Canada lowered their price objective on Avantor from $33.00 to $31.00 and set an “outperform” rating for the company in a research report on Monday, February 10th. Stifel Nicolaus cut their target price on shares of Avantor from $28.00 to $26.00 and set a “buy” rating on the stock in a report on Monday, February 10th. Citigroup decreased their target price on shares of Avantor from $22.00 to $18.00 and set a “neutral” rating on the stock in a research note on Tuesday, March 4th. Finally, UBS Group reissued a “neutral” rating and set a $25.00 price target (down previously from $29.00) on shares of Avantor in a research report on Friday, January 17th. Three analysts have rated the stock with a hold rating and nine have assigned a buy rating to the company. According to MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $25.50.

Insiders Place Their Bets

In related news, CAO Steven W. Eck sold 4,907 shares of Avantor stock in a transaction dated Wednesday, February 26th. The shares were sold at an average price of $17.53, for a total transaction of $86,019.71. Following the completion of the transaction, the chief accounting officer now directly owns 40,604 shares of the company’s stock, valued at $711,788.12. This trade represents a 10.78 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, EVP James Bramwell sold 3,758 shares of the business’s stock in a transaction dated Wednesday, February 26th. The stock was sold at an average price of $17.53, for a total transaction of $65,877.74. Following the sale, the executive vice president now directly owns 87,379 shares in the company, valued at $1,531,753.87. The trade was a 4.12 % decrease in their position. The disclosure for this sale can be found here. Company insiders own 1.50% of the company’s stock.

Avantor Stock Up 1.4 %

Shares of Avantor stock opened at $16.53 on Tuesday. The company has a current ratio of 1.07, a quick ratio of 0.70 and a debt-to-equity ratio of 0.54. Avantor, Inc. has a 12-month low of $15.37 and a 12-month high of $28.00. The company has a market cap of $11.25 billion, a P/E ratio of 15.89, a PEG ratio of 1.55 and a beta of 1.30. The company’s fifty day simple moving average is $19.40 and its two-hundred day simple moving average is $21.94.

Avantor (NYSE:AVTR) last announced its quarterly earnings results on Wednesday, February 12th. The company reported $0.27 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.26 by $0.01. Avantor had a net margin of 10.49% and a return on equity of 12.17%. During the same quarter in the previous year, the company earned $0.22 EPS. Research analysts anticipate that Avantor, Inc. will post 1.06 EPS for the current year.

Avantor Company Profile

Avantor, Inc engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips.